Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection.

about

Usefulness of Bronchoscopic Rebiopsy of Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor.A new predictive scoring system based on clinical data and computed tomography features for diagnosing EGFR-mutated lung adenocarcinoma.

P2860

Q52723939-55E21D43-246B-40FB-BCCB-6435D19632BA Q55058129-EA8FBADF-59C8-460A-864D-A7134113CD6C

P2860

Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection.

Item

http://www.wikidata.org/entity/Q47980253

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Repeat biopsy of patients with ...... s on T790M mutation detection.

@en

Repeat biopsy of patients with ...... s on T790M mutation detection.

@nl

type

Item

label

Repeat biopsy of patients with ...... s on T790M mutation detection.

@en

Repeat biopsy of patients with ...... s on T790M mutation detection.

@nl

prefLabel

Repeat biopsy of patients with ...... s on T790M mutation detection.

@en

Repeat biopsy of patients with ...... s on T790M mutation detection.

@nl

P1476

Repeat biopsy of patients with ...... s on T790M mutation detection.

@en

P2093

Bhumsuk Keam

http://www.w3.org/2001/XMLSchema#string

Chang Min Park

http://www.w3.org/2001/XMLSchema#string

Dong-Wan Kim

http://www.w3.org/2001/XMLSchema#string

Hyungjin Kim

http://www.w3.org/2001/XMLSchema#string

Kum Ju Chae

http://www.w3.org/2001/XMLSchema#string

Miso Kim

http://www.w3.org/2001/XMLSchema#string

Soon Ho Yoon

http://www.w3.org/2001/XMLSchema#string

Tae Min Kim

http://www.w3.org/2001/XMLSchema#string

P2860

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer.

Rociletinib in EGFR-mutated non-small-cell lung cancer.

Cancer statistics, 2012

Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation.

Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay.

P2888

s00330-017-5006-6

P304

861-868

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00330-017-5006-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jin Mo Goo

P577

2017-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28786010

http://www.w3.org/2001/XMLSchema#string

Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection.

about

P2860

P2860

Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698